It’s not hard to imagine AbbVie’s management team presented with PowerPoint decks showing ... the revenues lost as Humira succumbed to biosimilar competition, and leave the company with ...
Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...
Panelists discuss how biosimilars have significantly reduced health care costs in the US, with health care systems experiencing significant savings across various therapeutic areas. These cost ...
The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations. Avtozma, ...
Panelists discuss how employers optimize biosimilar uptake through strategic formulary design, financial incentives, and provider education, enabling health care systems to achieve substantial ...
Objectives The widespread use of proton pump inhibitors (PPIs) raised concerns on the safety of long-term use of these drugs. Community pharmacists have great responsibility of educating patients on ...
Perpetual’s directors have been summoned to a board meeting scheduled for late Tuesday, as KKR prepares to rejig a $2.2 billion bid that was stung by a hefty tax bill.
Here's a pretty strange Roblox game, where you play as a student in a classroom. Unlike in a real school, you can pay points to do absurd things like throw a toilet, scream at your teacher, break your ...
Get free access to Word, Excel, and PowerPoint using Microsoft 365 for the web (formerly Office).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results